Infectious Diseases Mpox Resurgence: A Global Wake-Up Call for Zoonotic Disease PreparednessGlobal Biodefense StaffSeptember 4, 2025
Preparedness Drug Shortages, Public Health Preparedness, and the Contradictions of U.S. PolicyGlobal Biodefense StaffSeptember 3, 2025
Policy + Initiatives PAHPA at a Crossroads: How Congressional Inaction Risks America’s Health SecurityGlobal Biodefense StaffSeptember 2, 2025
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine Industry News November 23, 2012 …
Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers Contracts + Grants June 19, 2012 …